Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis—authors' reply

Sherry Yueh Hsia Chiu, Kuo Chin Chang, Tsung Hui Hu, Rong Nan Chien*

*Corresponding author for this work

Research output: Contribution to journalJournal Letter peer-review

Original languageEnglish
Pages (from-to)1042-1043
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume53
Issue number9
DOIs
StatePublished - 05 2021

Cite this